Abstract
Non-classical congenital adrenal hyperplasia (NCAH) is a morbid condition sustained by the reduced function of one of the enzymes involved in the adrenal steroid biosynthesis pathway, mainly the 21-hydroxylase. Different degrees of enzyme activity impairment determine different clinical pictures, with childhood or post-pubertal onset. The aim of this study was to evaluate the relationship between genotype, phenotype, and adrenal hormonal levels in a group of 66 patients affected by NCAH attending outpatient pediatric or endocrinological Clinics. Our findings show that age at pubarche/menarche was significantly younger, height SD score) and Δ bone age-chronological age were significantly higher in patients with a more severe enzyme activity impairment, while cutaneous androgenization and menstrual irregularities in post-pubertal girls were not related to the grading of genotype.
Similar content being viewed by others
References
Azziz R, Owerbach D. Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation. Am J Obstet Gynecol 1995, 172: 914–8.
White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000, 21: 245–91.
Deneux C, Tardy V, Dib A, et al. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2001, 86: 207–13.
Wedell A, Thilén A, Ritzén EM, Stengler B, Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 1994, 78: 1145–52.
Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995, 80: 2322–9.
Jääskeläinen J, Levo A, Voutilainen R, Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 1997, 82: 3293–7.
Bachega TA, Billerbeck AE, Madureira G, et al. Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1998, 83: 4416–9.
Speiser PW, Knochenhauer ES, Dewailly D, Fruzzetti F, Marcondes JA, Azziz R. A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. Mol Genet Metab 2000, 71: 527–34.
Weintrob N, Brautbar C, Pertzelan A, et al. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency. Eur J Endocrinol 2000, 143: 397–403.
Bachega TA, Billerbeck AE, Marcondes JA, Madureira G, Arnhold IJ, Mendonca BB. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 2000, 52: 601–7.
Balsamo A, Cacciari E, Baldazzi L, et al. CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region. Clin Endocrinol (Oxf) 2000, 53: 117–25.
Dracopoulou-Vabouli M, Maniati-Christidi M, Dacou-Voutetakis C The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001, 86: 2845–8.
Dain LB, Buzzalino ND, Oneto A, et al. Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients. Clin Endrocrinol 2002, 56: 239–45.
Torres N, Mello MP, Germano CM, Elias LL, Moreira AC, Castro M. Phenotype and genotype correlation of the microconversion from the CYP21A1 P to the CYP21A2 gene in congenital adrenal hyperplasia. Braz J Med Biol Res 2003, 36: 1311–8.
Trakakis E, Laggas D, Salamalekis E, Creatsas G. 21-Hydroxylase deficiency: from molecular genetics to clinical presentation. J Endocrinol Invest 2005, 28: 187–92.
New MI. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J. Clin Endocrinol Metab 2006, 91: 4205–14.
Wilson RC, Nimkarn S, Dumic M, et al. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 2007, 90: 414–21.
Admoni O, Israel S, Lavi I, Gur M, Tenenbaum-Rakover Y. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype. Clin Endocrinol (Oxf) 2006, 64: 645–51.
Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J. Clin. Endocrinol Metab 2000, 85: 1059–65.
Greulich WW, Pyle SI. Radiographic Atlas of skeletal development of the hand and wrist. 2nd ed. Stanford Stanford University Press, 1959.
Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976, 51: 170–1.
Ferriman D, Gallwey JD. Clinical assessment of body hair growth in woman. J Clin Endocrinol Metab 1961, 21: 1440–7.
New MI, Lorenzen F, Lerner A, et al. Genotyping steroid 21 hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983, 57: 320–6.
Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acid Res 2003, 31: 3812–4.
Buckbinder L. The glucocorticoid receptor: molecular mechanisms and new therapeutic opportunities. Inflamm Res 2002, 51: 167–9.
Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotype in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000, 85: 1059–65.
Atmaca H, Tanriverdi F, Unluhizarci K, Bayram F, Kelestimur F. Investigation of adrenal functions in patients with idiopathic hyperandrogenemia. Eur J Endocrinol 2006, 155: 307–11.
Glintborg D, Hermann AP, Brusgaard K, Hangaard J, Hagen C, Andersen M. Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls. J Clin Endocrinol Metab 2005, 90: 1347–53.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Einaudi, S., Napolitano, E., Restivo, F. et al. Genotype, phenotype and hormonal levels correlation in non-classical congenital adrenal hyperplasia. J Endocrinol Invest 34, 660–664 (2011). https://doi.org/10.3275/7410
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3275/7410